High rate of expression of multidrug resistance-associated P-glycoprotein in human endometrial carcinoma and normal endometrial tissue. (Q54254612)

26 May 2018

title

High rate of expression of multidrug resistance-associated P-glycoprotein in human endometrial carcinoma and normal endometrial tissue. (English)

1 reference

26 May 2018

main subject

multiple drug resistance

1 reference

inferred from title

endometrial carcinoma

1 reference

2

1 reference

26 May 2018

author name string

J Schneider

1

1 reference

26 May 2018

M M Centeno

3

1 reference

26 May 2018

J Mattern

4

1 reference

26 May 2018

F J Rodríguez-Escudero

5

1 reference

26 May 2018

M Volm

6

1 reference

26 May 2018

publication date

1 January 1993

1 reference

26 May 2018

European Journal of Cancer

published in

1 reference

26 May 2018

volume

29A

1 reference

26 May 2018

page(s)

554-558

1 reference

26 May 2018

issue

4

1 reference

26 May 2018

Multiple-drug resistance in human cancer

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2805%2980150-9

7 January 2021

https://api.crossref.org/works/10.1016%2FS0959-8049%2805%2980150-9

1 reference

7 January 2021

Clinical Relevance of Immunohistochemical Detection of Multidrug Resistance P-Glycoprotein in Breast Carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2805%2980150-9

7 January 2021

Immunohistochemical detection of P-glycoprotein: prognostic correlation in soft tissue sarcoma of childhood

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2805%2980150-9

7 January 2021

Does P-Glycoprotein Predict Response to Chemotherapy, and If So, Is There a Reliable Way to Detect It?

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2805%2980150-9

7 January 2021

Laboratory assessment of P-glycoprotein in cancer chemosensitivity testing

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2805%2980150-9

7 January 2021

Detection of the multidrug resistant phenotype in human tumours by monoclonal antibodies and the streptavidin-biotinylated phycoerythrin complex method

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2805%2980150-9

7 January 2021

P-glycoprotein expression in treated and untreated human breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2805%2980150-9

7 January 2021

Immunohistochemical detection of the multi-drug-resistance marker P-glycoprotein in uterine cervical carcinomas and normal cervical tissue

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2805%2980150-9

7 January 2021

Detection of P-glycoprotein in multidrug-resistant cell lines by monoclonal antibodies

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2805%2980150-9

7 January 2021

Monoclonal antibody JSB-1 detects a highly conserved epitope on the P-glycoprotein associated with multi-drug-resistance

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2805%2980150-9

7 January 2021

Overexpression of P-glycoprotein in rat hepatocellular carcinomas induced with N-nitrosomorpholine

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2805%2980150-9

7 January 2021

An altered pattern of cross-resistance in multidrug-resistant human cells results from spontaneous mutations in the mdr1 (P-glycoprotein) gene

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2805%2980150-9

7 January 2021

Two members of the mouse mdr gene family confer multidrug resistance with overlapping but distinct drug specificities

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2805%2980150-9

7 January 2021

Some monoclonal antibody reagents (C219 and JSB-1) to P-glycoprotein contain antibodies to blood group A carbohydrate determinants: a problem of quality control for immunohistochemical analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2805%2980150-9

7 January 2021

Immunohistochemical analysis of P-glycoprotein expression correlated with chemotherapy resistance in locally advanced breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2805%2980150-9

7 January 2021

Activity of various amphiphilic agents in reversing multidrug resistance of L 1210 cells.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2805%2980150-9

7 January 2021

Tamoxifen therapy in advanced/recurrent endometrial carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2805%2980150-9

7 January 2021

10.1016/S0959-8049(05)80150-9

Identifiers

DOI

1 reference

26 May 2018

PubMed ID

8094623

1 reference

26 May 2018